Crohn's Disease Latest Advances

High-resolution promoter interaction analysis implicates genes involved in the activation of Type 3 Innate Lymphoid Cells in autoimmune disease risk.

Journal: bioRxiv : the preprint server for biology

Published: January 23, 2026

Gut-Brain Axis in Inflammatory Bowel Disease: Pathogenesis and Therapeutics.

Journal: Archives of internal medicine research

Published: January 22, 2026

The Drug Update: Recent drug approvals, winter 2026 edition.

Journal: The Nurse practitioner

Published: January 22, 2026

Epidemiology of inflammatory bowel disease in southern Spain - A population-based study of native and migrant populations (2012-2022).

Journal: Revista espanola de enfermedades digestivas

Published: January 22, 2026

Redefining Crohn Disease Phenotypes: The Rationale for Recognizing Probable Strictures.

Journal: AJR. American journal of roentgenology

Published: January 21, 2026

Exercise self-efficacy in young and middle-aged patients with Crohn's disease: Latent profile analysis and influencing factors.

Journal: Journal of health psychology

Published: January 20, 2026

Effectiveness of ustekinumab and improvement in real-world work productivity and associated indirect costs in patients with moderate-severe Crohn's disease in the United States of America.

Journal: Current medical research and opinion

Published: January 19, 2026

Diagnostic value of serum lipocalin-2 in Egyptian patients with inflammatory bowel disease: A case-control study.

Journal: The Egyptian journal of immunology

Published: January 17, 2026

A 17-Year-Old Male Adolescent With Refractory Crohn's Disease Managed With Upadacitinib and Risankizumab Combination Therapy: A Case Report and Review of Current Evidence.

Journal: The American journal of case reports

Published: January 16, 2026

Complete genomes of Phascolarctobacterium faecium isolates obtained from pediatric mucosal-luminal interface aspirate samples.

Journal: Microbiology resource announcements

Published: January 16, 2026

Submucosal bowel wall layer thickness predicts endoscopic activity in Crohn's disease.

Journal: Ultraschall in der Medizin (Stuttgart, Germany : 1980)

Published: January 15, 2026

Ultra-Processed Food Consumption and Colorectal Cancer Risk: a Systematic Review and 2-Stage Mediation Meta-Analysis.

Journal: Nutrition reviews

Published: January 14, 2026

Crohn's Disease Latest Advances

Find the Latest Research About Crohn's Disease

High-resolution promoter interaction analysis implicates genes involved in the activation of Type 3 Innate Lymphoid Cells in autoimmune disease risk.

High-resolution promoter interaction analysis implicates genes involved in the activation of Type 3 Innate Lymphoid Cells in autoimmune disease risk.

Gut-Brain Axis in Inflammatory Bowel Disease: Pathogenesis and Therapeutics.

Gut-Brain Axis in Inflammatory Bowel Disease: Pathogenesis and Therapeutics.

The Drug Update: Recent drug approvals, winter 2026 edition.

The Drug Update: Recent drug approvals, winter 2026 edition.

Epidemiology of inflammatory bowel disease in southern Spain - A population-based study of native and migrant populations (2012-2022).

Epidemiology of inflammatory bowel disease in southern Spain - A population-based study of native and migrant populations (2012-2022).

Redefining Crohn Disease Phenotypes: The Rationale for Recognizing Probable Strictures.

Redefining Crohn Disease Phenotypes: The Rationale for Recognizing Probable Strictures.

Exercise self-efficacy in young and middle-aged patients with Crohn's disease: Latent profile analysis and influencing factors.

Exercise self-efficacy in young and middle-aged patients with Crohn's disease: Latent profile analysis and influencing factors.

Effectiveness of ustekinumab and improvement in real-world work productivity and associated indirect costs in patients with moderate-severe Crohn's disease in the United States of America.

Effectiveness of ustekinumab and improvement in real-world work productivity and associated indirect costs in patients with moderate-severe Crohn's disease in the United States of America.

Diagnostic value of serum lipocalin-2 in Egyptian patients with inflammatory bowel disease: A case-control study.

Diagnostic value of serum lipocalin-2 in Egyptian patients with inflammatory bowel disease: A case-control study.

A 17-Year-Old Male Adolescent With Refractory Crohn's Disease Managed With Upadacitinib and Risankizumab Combination Therapy: A Case Report and Review of Current Evidence.

A 17-Year-Old Male Adolescent With Refractory Crohn's Disease Managed With Upadacitinib and Risankizumab Combination Therapy: A Case Report and Review of Current Evidence.

Complete genomes of Phascolarctobacterium faecium isolates obtained from pediatric mucosal-luminal interface aspirate samples.

Complete genomes of Phascolarctobacterium faecium isolates obtained from pediatric mucosal-luminal interface aspirate samples.

Submucosal bowel wall layer thickness predicts endoscopic activity in Crohn's disease.

Submucosal bowel wall layer thickness predicts endoscopic activity in Crohn's disease.

Ultra-Processed Food Consumption and Colorectal Cancer Risk: a Systematic Review and 2-Stage Mediation Meta-Analysis.

Ultra-Processed Food Consumption and Colorectal Cancer Risk: a Systematic Review and 2-Stage Mediation Meta-Analysis.